experimental diabetes cardiovascular tissues during early stages of Upregulation of PKC genes and isozymes in
暂无分享,去创建一个
G. King | S. Yuan | F. Korompai | M. Irwin | Z. Xia | Mack H. Wu | P. Geraldes | S. Lei | Yanan Liu | Xiaoting Gao | X. Mao | Tingting Wang | G. Wong | Rajprasad Loganathan | L. Novikova | I. Boulatnikov | I. Smirnova | Igor G. Boulatnikov
[1] Joseph L Evans,et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.
[2] P. Arner. Insulin resistance in type 2 diabetes: role of fatty acids , 2002, Diabetes/metabolism research and reviews.
[3] A. Goldfine,et al. Inhibition of Protein Kinase C&bgr; Prevents Impaired Endothelium-Dependent Vasodilation Caused by Hyperglycemia in Humans , 2002, Circulation research.
[4] D. Gutterman. Vascular dysfunction in hyperglycemia: is protein kinase C the culprit? , 2002, Circulation research.
[5] G. King,et al. Protein kinase C and the development of diabetic vascular complications , 2001, Diabetic medicine : a journal of the British Diabetic Association.
[6] A. Newton,et al. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. , 2001, Chemical reviews.
[7] I. Idris,et al. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes , 2001, Diabetologia.
[8] H. Nawata,et al. Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase c activity in cultured aortic smooth muscle cells , 2001, Diabetologia.
[9] A. Fields,et al. Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. , 2001, Cancer research.
[10] S. Bustin. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. , 2000, Journal of molecular endocrinology.
[11] P A Insel,et al. Protein kinase C isozymes and the regulation of diverse cell responses. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[12] J. P. Walsh,et al. Fatty acids modulate protein kinase C activation in porcine vascular smooth muscle cells independently of their effect on de novo diacylglycerol synthesis , 2000, Diabetologia.
[13] S. Yuan,et al. Protein Kinase C Activation Contributes to Microvascular Barrier Dysfunction in the Heart at Early Stages of Diabetes , 2000, Circulation research.
[14] M. Meier,et al. Protein kinase C activation and its pharmacological inhibition in vascular disease , 2000, Vascular medicine.
[15] E. Ustinova,et al. Ammonium Chloride Potentiation of Streptozotocin-Induced Diabetes in Juvenile Pigs , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[16] G. King,et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] I. West. Radicals and oxidative stress in diabetes , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[18] F. Luft,et al. Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats. , 1999, Kidney international.
[19] N. Dhalla,et al. Changes in cardiac protein kinase C activities and isozymes in streptozotocin-induced diabetes. , 1999, American journal of physiology. Endocrinology and metabolism.
[20] M. Kazanietz,et al. New insights into the regulation of protein kinase C and novel phorbol ester receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] G. King,et al. Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. , 1999, Circulation.
[22] P. Simpson. β-Protein Kinase C and Hypertrophic Signaling in Human Heart Failure , 1999 .
[23] G. King,et al. In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. , 1998, The Journal of clinical investigation.
[24] P. Buttrick,et al. Experimental diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. , 1997, Circulation research.
[25] S. Bursell,et al. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. , 1997, Investigative ophthalmology & visual science.
[26] G. Fishman,et al. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. , 1997, The Journal of clinical investigation.
[27] R. Dietz,et al. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. , 1997, Circulation research.
[28] G. King,et al. Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[29] G. King,et al. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. , 1997, The Journal of clinical investigation.
[30] S. Bursell,et al. Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.
[31] S. Bursell,et al. Normalization of Diacylglycerol-Protein Kinase C Activation by Vitamin E in Aorta of Diabetic Rats and Cultured Rat Smooth Muscle Cells Exposed to Elevated Glucose Levels , 1994, Diabetes.
[32] G. King,et al. Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. , 1994, The American journal of physiology.
[33] G. King,et al. Characterization of the Mechanism for the Chronic Activation of Diacylglycerol-Protein Kinase C Pathway in Diabetes and Hypergalactosemia , 1994, Diabetes.
[34] F. DeRubertis,et al. Activation of Protein Kinase C in Glomerular Cells in Diabetes: Mechanisms and Potential Links to the Pathogenesis of Diabetic Glomerulopathy , 1994, Diabetes.
[35] S. Bursell,et al. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. , 1993, The American journal of physiology.
[36] G. King,et al. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. McNeill,et al. Protein kinase C activity is altered in diabetic rat hearts. , 1992, Biochemical and biophysical research communications.
[38] Y. Nishizuka,et al. Expression and properties of two types of protein kinase C: alternative splicing from a single gene. , 1987, Science.
[39] D. Mochly‐Rosen,et al. Anchoring proteins for protein kinase C: a means for isozyme selectivity. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] M. Given,et al. Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat. , 1998, American journal of physiology. Heart and circulatory physiology.
[41] S. Steinberg,et al. Protein kinase C isoform diversity in the heart. , 1995, Journal of molecular and cellular cardiology.
[42] B. Wolf,et al. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. , 1991, The Journal of clinical investigation.
[43] M. Brownlee. Insight Review Articles , 2022 .